Physical activity and hospitalization for exacerbation of COPD

Chest
Fabio PittaRik Gosselink

Abstract

Acute exacerbations (AEs) have a negative impact on various aspects of the progression of COPD, but objective and detailed data on the impact of hospitalizations for an AE on physical activity are not available. Objective and measurements: We aimed to investigate physical activity using an activity monitor (DynaPort; McRoberts; the Hague, the Netherlands), pulmonary function, muscle force, 6-min walking distance, and arterial blood gas levels in 17 patients (mean age, 69 +/- 9 years [+/- SD]; body mass index, 24 +/- 5 kg/m(2)) at the beginning and end of a hospitalization period for an AE and 1 month after discharge. Time spent on weight-bearing activities (walking and standing) was markedly low both at day 2 and day 7 of hospitalization (median, 7%; interquartile range [IQR], 3 to 18% of the time during the day; and median, 9%; IQR, 7 to 21%, respectively) and 1 month after discharge (median, 19% [IQR, 10 to 34%]; Friedman test, p = 0.13). Time spent on weight-bearing activities was positively correlated to quadriceps force at the end of the hospitalization period (r = 0.47; p = 0.048). Patients with hospitalization for an AE in the previous year had an even lower activity level when compared to those without a recent hospital...Continue Reading

References

Feb 1, 1987·Annals of Internal Medicine·N R AnthonisenN A Nelson
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·M DecramerP Rogiers
Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·W H ThompsonJ J Crowley
Dec 5, 1997·The European Respiratory Journal·M A VermeerenE F Wouters
May 29, 1998·American Journal of Respiratory and Critical Care Medicine·T A SeemungalJ A Wedzicha
Feb 2, 1999·Respiratory Medicine·D K KirstenH Magnussen
Oct 9, 1999·The European Respiratory Journal·T TroostersM Decramer
May 12, 2000·American Journal of Respiratory and Critical Care Medicine·T A SeemungalJ A Wedzicha
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·E C CreutzbergA M Schols
Aug 15, 2001·Diagnostic Microbiology and Infectious Disease·D LiebermanI Boldur
Jan 30, 2003·Thorax·J Garcia-AymerichUNKNOWN Estudi del Factors de Risc d'Agudització de la MPOC investigators
Jun 6, 2003·Clinical Rehabilitation·Tony GiantomasoRajini Sankaran
Jul 29, 2003·The European Respiratory Journal·L M FabbriUNKNOWN GOLD Scientific Committee
Mar 5, 2004·The New England Journal of Medicine·Bartolome R CelliHoward J Cabral
Sep 9, 2004·Medicine and Science in Sports and Exercise·Catrine Tudor-LockeC Dexter Kimsey
Dec 8, 2004·American Journal of Respiratory and Critical Care Medicine·Gavin C DonaldsonJadwiga A Wedzicha
Jan 25, 2005·American Journal of Respiratory and Critical Care Medicine·Fabio PittaRik Gosselink
Oct 11, 2005·Archives of Physical Medicine and Rehabilitation·Fabio PittaRik Gosselink
Mar 1, 1993·The European Respiratory Journal·P H QuanjerJ C Yernault

❮ Previous
Next ❯

Citations

Apr 29, 2009·Medizinische Klinik·Helgo MagnussenHenrik Watz
Jul 15, 2009·Journal of General Internal Medicine·Angeliki M TsimogianniAnastasia Kotanidou
Jun 13, 2012·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Anke J M C LahaijeP N Richard Dekhuijzen
Jan 11, 2012·Current Opinion in Pulmonary Medicine·Angela M AbbatecolaEnrico E Guffanti
Oct 22, 2013·Journal of Cardiopulmonary Rehabilitation and Prevention·Anne-Kathrin Rausch OsthoffArnoldus J R van Gestel
Jan 15, 2010·Current Opinion in Pulmonary Medicine·Roberto A Rabinovich, Jordi Vilaró
Mar 11, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Tam EatonJohn Kolbe
Feb 9, 2007·Thorax·Michael C Steiner
Dec 12, 2012·International Journal of Telemedicine and Applications·Monique TabakHermie J Hermens
Feb 28, 2009·American Journal of Respiratory and Critical Care Medicine·Judith Garcia-AymerichCarlos A Camargo
Feb 6, 2010·American Journal of Respiratory and Critical Care Medicine·Thierry TroostersRik Gosselink
May 13, 2010·American Journal of Respiratory and Critical Care Medicine·Enrico CliniErnesto Crisafulli
Aug 24, 2010·Respiratory Research·Marie-Kathrin BreyerSylvia Hartl
Nov 16, 2013·Respiratory Research·Thierry TroostersKaroly Kulich
Jun 21, 2013·Respiratory Research·Tsai-Yu WangHan-Pin Kuo
Dec 20, 2011·BMC Pulmonary Medicine·Fran DyerNicholas S Hopkinson
Nov 21, 2013·BMC Medicine·Eui-Sik SuhNicholas Hart
Feb 7, 2013·Multidisciplinary Respiratory Medicine·Nicoleta BerticiVoicu Tudorache
Feb 12, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Richard RussellIdelle Weisman
Jun 6, 2012·International Journal of Chronic Obstructive Pulmonary Disease·W Darlene ReidPat G Camp
Jan 8, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Osamu HatajiOsamu Taguchi
Oct 22, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Thys van der MolenJanwillem W H Kocks
Sep 17, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Atsuyoshi KawagoshiTakanobu Shioya
Feb 4, 2014·International Journal of Chronic Obstructive Pulmonary Disease·Olivia ThorpeKylie Johnston
Jan 1, 2010·Sensors·Alberto G Bonomi, Stefano Salati
May 2, 2014·BioMed Research International·Nele CielenGhislaine Gayan-Ramirez
Oct 17, 2013·American Journal of Respiratory and Critical Care Medicine·Martijn A SpruitUNKNOWN ATS/ERS Task Force on Pulmonary Rehabilitation
Jan 1, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Narelle S CoxAnne E Holland
Jun 3, 2014·BMC Pulmonary Medicine·Ayedh D AlahmariGavin C Donaldson
Apr 10, 2014·Annals of the American Thoracic Society·Huong Q NguyenMichael K Gould
May 3, 2014·American Journal of Respiratory and Critical Care Medicine·François MaltaisUNKNOWN ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD
Jun 1, 2014·Archives of Physical Medicine and Rehabilitation·Rodrigo C Borges, Celso R Carvalho
May 25, 2011·Wiener klinische Wochenschrift·Uros MeglicMitja Lainscak
Sep 14, 2011·Respiration; International Review of Thoracic Diseases·Akihito SuginoMasakazu Ichinose
Mar 24, 2012·Respiration; International Review of Thoracic Diseases·Julia L KellyNicholas S Hopkinson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.